MODIFIED - 'MODIFIED PONTICELLI REGIMEN' - FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY

被引：0
|
作者：
Nagaraju, Shankar Prasad [1 ]
Parthasarathy, Rajeevalochana [1 ]
Prabhu, Ravindra Attur [1 ]
Kosuru, Srinivas [1 ]
Rangaswamy, Dharshan [1 ]
Mareddy, Aswani Srinivas [1 ]
Madken, Mohit [1 ]
Kaza, Sindhu [1 ]
Rao, Srikanth Prasad [1 ]
Laxminarayana, Sindhura Lakshmi Koulmane [2 ]
Guddattu, Vasudeva [3 ]
机构：
[1] Manipal Univ, Nephrol, Kasturba Med Coll, Manipal, Karnataka, India
[2] Manipal Univ, Melaka Manipal Med Coll, Pathol, Manipal, Karnataka, India
[3] Manipal Univ, Kasturba Med Coll, Stat, Manipal, Karnataka, India
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP145
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial
    Ramachandran, Raja
    Hn, Harsha Kumar
    Kumar, Vinod
    Nada, Ritambhra
    Yadav, Ashok Kumar
    Goyal, Ajay
    Kumar, Vivek
    Rathi, Manish
    Jha, Vivekanand
    Gupta, Krishan Lal
    Sakhuja, Vinay
    Kohli, Harbir Singh
    NEPHROLOGY, 2016, 21 (02) : 139 - 146
  • [2] A Study Comparing Rituximab and Modified Ponticelli (MP) Regimen in Primary Membranous Nephropathy(PMN)
    Kumar, Abhishek
    Chaudhury, Arpita Ray
    Gupta, Saugat D.
    Mukherjee, Sriranjan
    Sengupta, Moumita
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 513 - 513
  • [3] ROLE OF TACROLIMUS ONLY THERAPY IN MODIFIED PONTICELLI REGIMEN RESISTANT IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS
    Ramachandran, Raja
    Sharma, Vinod
    Nada, Ritambhra
    Jha, Vivekanand
    Gupta, Krishan Lal
    Kohli, Harbir Singh
    NEPHROLOGY, 2015, 20 (01) : 44 - 46
  • [4] STUDY OF HYPOTHALAMIC PITUITARY ADRENAL AXIS IN PATIENTS WITH MEMBRANOUS NEPHROPATHY RECEIVING MODIFIED PONTICELLI REGIMEN
    Kohli, Harbir
    Bhat, Ashok
    Bhansali, Anil
    Sud, Kamal
    Jha, V.
    Gupta, K. L.
    Sakhuja, Vinay
    NEPHROLOGY, 2005, 10 : A171 - A171
  • [5] Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model
    Hamilton, Patrick
    Kanigicherla, Durga
    Venning, Michael
    Brenchley, Paul
    Meads, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (12) : 2145 - 2155
  • [6] Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen
    Kohli, Harbir
    Bhansali, Anil
    Jha, Vivekanand
    Gupta, Kishan Lal
    Sud, Kamal
    Sakhuja, Vinay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 63 - 63
  • [7] TACROLIMUS WITH CORTICOSTEROIDS IS INFERIOR TO MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF PRIMARY MEMBRANOUS NEPHROPATHY: RESULTS AT 2 YEARS OF RANDOMIZATION
    Ramachandran, Raja
    Kumar, Vinod
    Nada, Ritambhra
    Kohli, Harbir Singh
    Jha, Vivekanand
    Gupta, Krishan Lal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 77 - 77
  • [8] Outcomes in Membranous Nephropathy Treated with Intravenous Cyclophosphamide and Oral Prednisolone (Modification of the Modified Ponticelli Regimen): A Single-Centre Experience
    Ritter, David William Jack
    Lange, Jacob Armstrong
    Makanjuola, David
    Cole, Nicholas
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [9] Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy
    Stefan, Gabriel
    Zugravu, Adrian
    Stancu, Simona
    JOURNAL OF NEPHROLOGY, 2023, 36 (02) : 293 - 295
  • [10] Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy
    Gabriel Ștefan
    Adrian Zugravu
    Simona Stancu
    Journal of Nephrology, 2023, 36 : 293 - 295
12345